Nutritional assessment for cancer patient;Evaluación nutricional del paciente con cancer

Nutricion Hospitalaria

Volumn 27, Issue 2, 2012, Pages 516-523

  Valenzuela Landaeta, K ^a   Rojas, P ^a   Basfi fer, K ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Cancer; Malnutrition; Nutrition assessment; Weight loss

Indexed keywords

BODY COMPOSITION; BODY MASS; CACHEXIA; HUMAN; MALNUTRITION; NEOPLASM; NUTRITIONAL ASSESSMENT; PHYSICAL EXAMINATION; PROTEIN CALORIE MALNUTRITION; REVIEW; STANDARD; WEIGHT REDUCTION;

BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; HUMANS; MALNUTRITION; NEOPLASMS; NUTRITION ASSESSMENT; PHYSICAL EXAMINATION; PROTEIN-ENERGY MALNUTRITION; REFERENCE STANDARDS; WEIGHT LOSS;

EID: 84858732183     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.2.5525     Document Type: Article

References (57)

1. Tisdale M. Mechanisms of Cancer Cachexia. Physiol Rev 2009; 89: 381-410.
2. Isenring E, Cross G, Daniels L, Kellett E, Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutricional risk in oncology outpatients receiving chemothe-rapy. Support Care Cancer 2006; 14: 1152-1156.
3. Wu BW, Yin T, Cao WX, Gu ZD, Wang XJ, Yan M. Liu BY. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gastroenterol 2009; 15 (28): 3542-3549.
4. Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9 (Suppl. 2): S51-63.
5. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 2008; 67 (3): 257-62.
6. Delmore G. Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 1997; 5 (5): 376-80.
7. Slaviero KA, Read JA, Clarke SJ, Rivory LP. Baseline Nutritional Assessment in Advanced Cancer Patients.Receiving Palliative Chemotherapy. Nut Cancer 46 (2): 148-157.
8. García-Luna PP, Parejo Campos J, Pereira Cunill JL. Causes and impact of hyponutrition and cachexia in the oncologic patient. Nutr Hosp 2006; 21 (Suppl. 3): 10-6.
9. Tisdale MJ. Cancer Anorexia and Cachexia. Nutrition 2001; 17: 438-442.
10. Inui A. Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management. CA Cancer J Clin 2002; 52: 72-91.
11. Sánchez-Lara K, Sosa-Sánchez R, Green-Renner D y Méndez-Sánchez N. Observaciones sobre la patogénesis de la anorexia asociada a cáncer y su regulación por el sistema nervioso central. Nutr Hosp 2011; 26 (4): 677-684.
12. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D et al. Cachexia: a new definition. Clin Nutr 2008; 27 (6): 793-9.
13. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12 (5): 489-95.
14. Argilés JM. Cancer-associated malnutrition. Eu J Oncol Nurs 2005; 9: S39-S50.
15. Strasser F. Eating-related disorders in patients with advanced cancer. Support Care Cancer 2003; 11: 11-20.
16. Argilés JM, Busquets S, López-Soriano F. Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care 6: 401-406.
17. Bing C, Trayhurn P. Regulation of adipose tissue metabolism in cancer cachexia. Curr Opin in Clin Nutr Metab Care 2008; 11: 201-207.
18. Piskorz L, Lesiak T, Brocki M, Klimek-Piskorz E, Smigielski J, Misiak P and Jablonski S. Biochemical and functional indices of malnutrition in patients with operable, no microcellular lung cancer. Nut Hosp 2011; 26 (5).
19. Burckart K, Beca S, Urban RJ, Sheffield-Moore M. Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies. Curr Opin Clin Nutr Metab Care 2010; 13 (4): 410-6.
20. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevante. Am J Clin Nutr 2006; 83 (4): 735-43.
21. Tisdale MJ. Loss of skeletal muscle in cancer: biochemical mechanisms. Front Biosci 2001; 6: D164-74.
22. Dahlman I, Mejhert N, Linder K, Agustsson T, Mutch D, Kulyte A. Adipose tissue pathways envolved in weight loss of cancer cachexia et al. Br J Cancer 2010; 102 (10): 1541-8.
23. Bing C, Trayhurn P. Regulation of adipose tissue metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care 2008; 11 (3): 201-7.
24. Rydén M, Agustsson T, Laurencikiene J, Britton T, Sjölin E, Isaksson B et al. Lipolysis-Not Inflammation, Cell Death, or Lipogenesis-Is Involved in Adipose Tissue Loss in Cancer Cachexia. Cancer 2008; 113 (7): 1695-704.
25. Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 2005; 103 (10): 2189-98.
26. Barbosa-Silva MC. Subjective and objective nutritional assessment methods: what do they really assess? Curr Opin Clin Nutr Metab Care 2008; 11 (3): 248-54.
27. Laky B, Janda M, Cleghorn G, Obermair A. Comparison of different nutritional assessments and body composition measure-ments in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 2008; 87: 1678-85.
28. Gupta D, Lammersfeld CA, Vashi PG, Dahlk SL, Lis CG. Can subjective global assessment of nutritional status predict survival in ovarian cancer? J Ovarian Res 2008; 1 (1): 5.
29. Zorlini R, Akemi A, Cairo A, Salete Costa Gurgel M. Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp 2008; 23 (6): 577-583.
30. Gómez-Candela C, Luengo LM, Cos AI, Martínez-Roque V, Iglesias C, Zamora P, González-Barón R. Subjective global assessment in neoplastic patient. Nutr Hosp 2003; XVIII (6): 353-357.
31. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56 (8): 779-85.
32. Marín M, Gómez C, Castillo R, Lourenço T, García M, Loria V et al. Nutritional risk evaluation and establishment of nutricional support in oncology patients according to the protocolo f the Spanish Nutrition and Cancer Group. Nutr Hosp 2008; 23 (5): 458-468.
33. Isenring E, Bauer J, Capra S. The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 2003; 57 (2): 305-9.
34. Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF. Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 2005; 59 (1): 35-40.
35. Gupta D, Lis CG, Vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer 2010; 18 (3): 373-81.
36. Gómez Candela C, Olivar Roldán J, García M, Marín M, Madero R et al. Utilidad de un método de cribado de malnutrición en pacientes con cáncer. Nutr Hosp 2010; 25 (3): 400-405.
37. Gudny Geirsdottir O, Thorsdottir I. Nutritional status of cancer patients in chemotherapy; dietary intake, nitrogen balance and screening. Food Nutr Res 2008; 52.
38. Deans DA, Tan BH, Wigmore SJ, Ross JA, De Beaux AC, Paterson-Brown S, Fearon KC. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009; 100: 63-69.
39. Nourissat A, Mille D, Delaroche G, Jacquin JP, Vergnon JM, Fournel P et al. Estimation of the risk for nutritional state degradation in patients with cancer: development of a screening tool based on results from a cross-sectional survey. Ann Oncol 2007; 18 (11): 1882-6.
40. Jagoe RT, Goodship TH, Gibson GJ. Nutritional Status of Patients Undergoing Lung Cancer Operations. Ann Thorac Surg 2001; 71 (3): 929-35.
41. Sarhill N, Mahmoud F, Walsh D, Nelson KA, Komurcu S, Davis M, Legrand S, Abdullah O, Rybicki L. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 2003; 11: 652-659.
42. Ryu SW, Kim IH. Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients. World J Gastroenterol 2010; 16 (26): 3310-3317.
43. Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc 2004; 104 (8): 1258-64.
44. Ellegård LH, Bosaeus IG. Biochemical indices to evaluate nutritional support for malignant disease. Clinica Chimica Acta 2008; 390: 23-27.
45. Shenkin A. Serum Prealbumin: Is It a Marker of Nutritional Status or of Risk of Malnutrition? Clinical Chemistry 2006; 52: 2177-2179.
46. Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clin Nutr 2008; 27 (3): 398-407.
47. Geisler JP, Linnemeier GC, Thomas AJ, Manahan KJ. Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 2007; 106: 128-131.
48. Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of Nutritional and Inflammatory Status of Advanced Colorectal Cancer Patients and Its Correlation With Survival. Nutr Cancer 2006; 55 (1): 78-85.
49. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM et al. Bioelectrical impedance análisis part I: review of principles and methods. Clin Nutr 2004; 23 (5): 1226-43.
50. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer 2009; 9: 37.
51. Gupta D, Lis CG, Dahlk SL, King J, Vashi PG, Grutsch JF, Lammersfeld CA. The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J 2008; 7: 19.
52. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis C. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008; 8: 249.
53. Santarpia L, Marra M, Montagnese C, Alfonsi L, Pasanisi F, Contaldo F. Prognostic significance of bioelectrical impedance phase angle in advanced cancer: Preliminary observations. Nutrition 2009; 25 (9): 930-1.
54. Barbosa-Silva MC, Barros AJ. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 2005; 8 (3): 311-7.
55. Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA. Bioelectrical impedance phase angle as a prognostic indicador in advanced pancreatic cancer. Br J Nutr 2004; 92: 957-962.
56. Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 2004; 80: 1634-8.
57. Mcmillan DC, Watson WS, Preston T, Mcardle CS. Lean body mass changes in cancer patients with weight loss. Clin Nutr 2000; 19 (6): 403-6.